Koray Onuk

876 total citations
19 papers, 466 citations indexed

About

Koray Onuk is a scholar working on Neurology, Cognitive Neuroscience and Occupational Therapy. According to data from OpenAlex, Koray Onuk has authored 19 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 8 papers in Cognitive Neuroscience and 4 papers in Occupational Therapy. Recurrent topics in Koray Onuk's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (9 papers) and Autism Spectrum Disorder Research (8 papers). Koray Onuk is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (9 papers) and Autism Spectrum Disorder Research (8 papers). Koray Onuk collaborates with scholars based in United States, Italy and Sweden. Koray Onuk's co-authors include Angelo Antonini, Kavita Sail, Per Odin, Anne Skalicky, Leah Kleinman, Thomas S. Marshall, A. Jon Stoessl, Juan Carlos Parra, Lars Bergmann and Yash J. Jalundhwala and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Parkinsonism & Related Disorders.

In The Last Decade

Koray Onuk

18 papers receiving 461 citations

Peers

Countries citing papers authored by Koray Onuk

Since Specialization

Citations

This map shows the geographic impact of Koray Onuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koray Onuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koray Onuk more than expected).

Fields of papers citing papers by Koray Onuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koray Onuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koray Onuk. The network helps show where Koray Onuk may publish in the future.

Co-authorship network of co-authors of Koray Onuk

This figure shows the co-authorship network connecting the top 25 collaborators of Koray Onuk. A scholar is included among the top collaborators of Koray Onuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koray Onuk. Koray Onuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort 2023 ·Parkinsonism & Related Disorders ·Hubert H. Fernandez, Per Odin, David G. Standaert, Tove Henriksen, Joohi Jimenez‐Shahed, S. Metz, Ali Alobaidi, (unknown), Pavnit Kukreja, Juan Carlos Parra, Jorge Zamudio, Koray Onuk, (unknown), Angelo Antonini	11
2	Evaluation of the Clinical Outcomes and Disease Burden in Advanced Parkinson’s Disease Patients: PROSPECT Study Preliminary Results (P10-11.009) 2023 ·Neurology ·Alberto J. Espay, Pilar Sánchez Alonso, (unknown), Carrie Ferguson, Kazuko Hasegawa, (unknown), Pavnit Kukreja, Koray Onuk, (unknown), Jorge Zamudio, Victor S.C. Fung	0
3	Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study 2022 ·Acta Neurologica Scandinavica ·Alfonso Fasano, Victor S.C. Fung, Klaus Seppi, Zvezdan Pirtošek, Annamária Takáts, Ali Alobaidi, Koray Onuk, Lars Bergmann, Juan Carlos Parra, Bülent Elibol	7
4	Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries 2022 ·Neurology and Therapy ·Angelo Antonini, Rajesh Pahwa, Per Odin, Tove Henriksen, Michael J. Soileau, (unknown), Stuart Isaacson, Aristide Merola, (unknown), Josefa Domingos, Ali Alobaidi, Yash J. Jalundhwala, (unknown), Juan Carlos Parra, Pavnit Kukreja, Koray Onuk, Lars Bergmann, James Pike, К. Ray Chaudhuri	10
5	Criteria for identification of advanced Parkinson’s disease: the results of the Italian subgroup of OBSERVE-PD observational study 2022 ·BMC Neurology ·Ambra Stefani, Alessandro Tessitore, Nicola Tambasco, Giovanni Cossu, Maria Gabriella Ceravolo, Giovanni Defazio, Francesca Morgante, Silvia Ramat, Gabriella Melzi, Giuliana Gualberti, Rocco Merolla, Koray Onuk, Leonardo Lopiano	14
6	Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries 2022 ·BMC Neurology ·Irene A. Malaty, Pablo Martínez‐Martín, К. Ray Chaudhuri, Per Odin, Matěj Škorvánek, Joohi Jimenez‐Shahed, Michael J. Soileau, (unknown), Josefa Domingos, Sarah Jones, Ali Alobaidi, Yash J. Jalundhwala, (unknown), Koray Onuk, Lars Bergmann, (unknown), Michelle Y. Lee, (unknown), Angelo Antonini	24
7	Characterization of advanced Parkinson’s disease in Germany: results of the non-interventional OBSERVE-PD study 2022 ·SHILAP Revista de lepidopterología ·David J. Pedrosa, Florin Gandor, Wolfgang H. Jost, (unknown), Koray Onuk, Lars Timmermann	8
8	Characterisation of advanced Parkinson’s disease: OBSERVE-PD observational study – results of the Swiss subgroup 2021 ·Swiss Medical Weekly ·Jens Carsten Möller, Christian R. Baumann, Pierre R. Burkhard, Alain Kaelin‐Lang, (unknown), Koray Onuk, Stephan Bohlhalter	3
9	Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications 2021 ·Parkinsonism & Related Disorders ·Angelo Antonini, Per Odin, Péter Schmidt, Fernando Cubillos, David G. Standaert, Tove Henriksen, Joohi Jimenez‐Shahed, Ali Alobaidi, Yash J. Jalundhwala, Yanjun Bao, Jorge Zamudio, Juan Carlos Parra, Pavnit Kukreja, Koray Onuk, Anne Skalicky, Leah Kleinman, Eddie Jones, S. Metz, Hubert H. Fernandez	36
10	Characterizing Advanced Parkinson’s Disease: Romanian Subanalysis from the OBSERVE-PD Study 2021 ·Parkinson s Disease ·József Attila Szász, Dragoş Cătălin Jianu, Mihaela Simu, (unknown), Adriana Octaviana Dulămea, Koray Onuk, (unknown), (unknown), Bogdan Ovidiu Popescu, Alfonso Fasano, Ovidiu Băjenaru	17
11	Az előrehaladott Parkinson-kór jellemzői a klinikai gyakorlatban: az OBSERVE-PD vizsgálat eredményei és a magyarországi alcsoport elemzése 2020 ·Ideggyógyászati Szemle ·Annamária Takáts, Zsuzsanna Aschermann, László Vécsei, Péter Klivènyi, Lívia Dézsi, Dénes Zádori, Attila Valikovics, (unknown), Koray Onuk, (unknown), Norbert Kovács	4
12	Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study 2020 ·Clinical Parkinsonism & Related Disorders ·Andrew Evans, Victor S.C. Fung, John D. O’Sullivan, Rick Stell, Richard P. White, (unknown), (unknown), Koray Onuk	8
13	Application of the ‘5-2-1’ Screening Criteria in Advanced Parkinson’s Disease: Interim Analysis of DUOGLOBE 2020 ·Neurodegenerative Disease Management ·Jason Aldred, (unknown), Angelo Antonini, Ovidiu Băjenaru, Lars Bergmann, Paul Bourgeois, Esther Cubo, Thomas L. Davis, Robert Iansek, Norbert Kovács, Pavnit Kukreja, Koray Onuk, Francesco E. Pontieri, Weining Robieson, Mustafa Siddiqui, Mihaela Simu, David G. Standaert, К. Ray Chaudhuri	28
14	MANAGE-PD: A clinician-reported tool to identify patients with Parkinson’s Disease inadequately controlled on oral medications – Results from vignette-based validation (P5.8-039) 2019 ·Neurology ·Angelo Antonini, Per Odin, Yash J. Jalundhwala, Péter Schmidt, Anne Skalicky, Leah Kleinman, Jorge Zamudio, Koray Onuk, Pavnit Kukreja, Yanjun Bao, Fernando Cubillos, Hubert H. Fernandez	2
15	Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients 2019 ·BMC Neurology ·Alfonso Fasano, Victor S.C. Fung, Leonardo Lopiano, Bülent Elibol, (unknown), Klaus Seppi, Annamária Takáts, Koray Onuk, Juan Carlos Parra, Lars Bergmann, Kavita Sail, Yash J. Jalundhwala, Zvezdan Pirtošek	81
16	Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach 2018 ·Current Medical Research and Opinion ·Angelo Antonini, A. Jon Stoessl, Leah Kleinman, Anne Skalicky, Thomas S. Marshall, Kavita Sail, Koray Onuk, Per Odin	172
17	The role and structure of the multidisciplinary team in the management of advanced Parkinson’s disease with a focus on the use of levodopa–carbidopa intestinal gel 2017 ·Journal of Multidisciplinary Healthcare ·Stephen Wørlich Pedersen, (unknown), Louis Liu, Dirk Domagk, Alison Forbes, Lars Bergmann, Koray Onuk, Ashley Yegin, Teus van Laar	15
18	An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients 2017 ·Advances in Therapy ·Rejko Krüger, Paul Lingor, Triantafyllos Doskas, J.M.L. Henselmans, Erik Hvid Danielsen, Oriol de Fàbregues, Alessandro Stefani, (unknown), Juan Carlos Parra, Koray Onuk, Ashley Yegin, Angelo Antonini	25
19	‘Advanced’ Parkinson’s disease characteristics in clinical practice: results from the OBSERVE-PD study, a cross-sectional observational study of 2615 patients (P6.001) 2017 ·Neurology ·Alfonso Fasano, Leonardo Lopiano, Bülent Elibol, (unknown), Klaus Seppi, Annamária Takáts, Koray Onuk, Juan Carlos Parra, Lars Bergmann, Ashley Yegin, Zvezdan Pirtošek	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact